Bigul

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and 'Code of Conduct for Prevention of Insider Trading' of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the trading window for dealing in securities of the Company will remain closed for designated persons and their immediate relatives with effect from 1st October, 2021 till 48 hours after the end of the Board Meeting wherein; the approval of Un-audited Financial Results for the Quarter and Half Year ended 30th September, 2021, would be considered, approved and declared.
30-09-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

In compliance to Regulation 44(3) of SEBI Listing Regulations, 2015; we hereby submit the Voting Results of the of the business transacted at the 34th Annual General Meeting (the '34th AGM') of the Company for the Financial Year 2020-21 held on Monday, September 27, 2021. Report of the Scrutinizer is enclosed herewith.
28-09-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Fredun Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
28-09-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the copies of newspaper advertisement published in Business Standard and Mumbai Lakshadeep, intimating about Extra Ordinary General Meeting of the Company which will be held on Tuesday, 19th October, 2021 at 11:00 am (IST) through Video Conferencing / Other Audio Visual Means in compliance with Ministry of Corporate Affairs Circular No. 20/2020 dated May 5, 2020 and 02/2021 dated January 13, 2021.
28-09-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Notice Of Extra Ordinary General Meeting On Tuesday, 19Th October, 2021

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose herewith the Notice of the Extra Ordinary General Meeting of the Company scheduled to be held as under: Day & Date : Tuesday, October 19, 2021 Time : 11.00 A.M., IST Mode : Through Video Conferencing ('VC') or / Other Audio-Visual Means ('OAVM'). Details for joining the meeting are provided in the enclosed Notice of EGM.
27-09-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the summary of the proceedings of 34th Annual General Meeting of the Company held on Monday, September 27, 2021 at 11:30am (IST) through Video Conferencing ('VC').
27-09-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Outcome Of Board Meeting Held On 22Nd September, 2021

Further to our intimation dated Wednesday, September 15, 2021 to consider the option of fund raising through Preferential Issue, the Board Meeting was held on Saturday, September 18, 2021 and Outcome of the same in terms of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ('Listing Regulations') was uploaded; wherein it was mentioned that the meeting was deferred and scheduled for Wednesday, September 22, 2021 due to heavy interest from various investors and certain investors had asked some more time to give their details. In furtherance to the same kindly find enclosed the outcome of meeting of Board of Directors held today i.e. Wednesday, September 22, 2021 in accordance with Listing Regulations.
22-09-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting

The meeting of Board of Directors pursuant to Regulation 29 of the Listing Regulations shall be held on Wednesday, September 22, 2021 to consider and evaluate proposals for raising of funds in one or more tranches by issuing one or more instruments comprising of Equity Shares, convertible securities of any other description or warrants, through Preferential Issue as may be decided by the Board to Promoters and Non Promoters, subject to such statutory/ regulatory approvals as may be necessary including the approval of shareholders of the Company, wherever required.
18-09-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Issue of Securities

This is to inform you that a meeting of the Board of Directors is scheduled to be held on Saturday, 18th September, 2021 at 11:00am to consider the following: 1. Issue of equity shares/warrants/fully convertible debentures or any other financial instrument which would be converted into / exchanged with equity shares at a later date, under Preferential Guidelines of SEBI to promoters and other eligible investors 2. To consider and approve the matter of holding an EGM/Postal Ballot 3. To consider the matter of making an application to BSE for in-principle approval 4. Any other matter with the permission of the Chair
15-09-2021
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed herewith information required under Regulation 30 of SEBI (LODR) Regulations, 2015. ' Fredun Pharmaceuticals Limited Bags $3.2 Million Order To Supply Cardiac and Anti-Infectives in the East African Countries' We request you to kindly take the above information on your records.
14-09-2021
Next Page
Close

Let's Open Free Demat Account